Imagion Biosystems features in Next Biotech — One ASX Med-Tech is Set to Transform the $100+Billion Cancer Diagnostic Market

“MagSense is a unique, non-invasive, patent protected technology that fits into myriad addressable cancer diagnostic markets collectively worth $166 billion dollars and growing at 7% annually.”
Read the feature.